by The Menstrual Cramps Treatment market is estimated to be valued at US$ 652.3 Mn in 2023 and is expected to exhibit a CAGR of 4.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Menstrual cramps or dysmenorrhea are painful cramps felt in the lower abdomen due to contractions of the uterus during menstruation. Products available for menstrual cramps treatment include pain relief medications such as Ibuprofen and Naproxen available as tablets, capsules or gel applicators and devices like hand warmer or heating pads to provide warmth and reduce pain. Transcutaneous electrical nerve stimulation (TENS) devices are also gaining popularity for non-drug treatment of menstrual cramps.
Market Dynamics:
The growth of the Menstrual Cramps Treatment Market is majorly driven by increasing demand for pain relief medications to effectively manage menstrual cramps. According to a study published in Iranian Journal of Pharmaceutical Research, up to 91% women reported moderate to severe menstrual pain during their reproductive years. Rising awareness about availability of effective medications and devices for pain management during periods is fueling the market growth. Secondly, surge in research and development activities for new products is also boosting the market. For instance, Sihuan Pharmaceutical launched MenstruEasy tablet containing proprietary compound prescription in 2021 for premenstrual syndrome and menstrual pain.
SWOT Analysis
Strength: The menstrual cramps treatment market offers various products to help provide relief from menstrual pain. Non-hormonal treatment options are growing in popularity as they avoid potential side effects. Many new products are entering the market, increasing treatment choices available to consumers.
Weakness:Awareness regarding menstrual cramps treatment options remains relatively low in developing regions. Limited research has been conducted on the long term effects of some medication, discouraging some women from use.
Opportunity: A rise in discretionary incomes allows women to spend more on pain management for menstrual cramps. Demand for herbal and homeopathic treatment options is growing due to their natural positioning and lack of side effects.
Threats: Stricter regulatory frameworks can delay market approval for new treatment products. Growing preference of women towards menstrual cups and other alternative period products may impact sales of medications.
Key Takeaways
The Global Menstrual Cramps Treatment Market Size is expected to witness high growth, exhibiting CAGR of 4.4% over the forecast period, due to increasing awareness regarding various treatment options available and growing demand for herbal and homeopathic medicines.
Regional analysis
Regional analysis shows that North America currently dominates the menstrual cramps treatment market. This is attributed to rising female population, growing awareness about available treatment choices, and presence of major players. However, Asia Pacific is poised to exhibit the fastest growth during the forecast period owing to improving access to menstrual care products, increasing discretionary spending on healthcare, and rising prevalence of menstrual disorders in the region.
Key players
Key players operating in the menstrual cramps treatment market include Stryker Corporation, SATELEC (Actongroup), Surgiform Innovative Surgical Products, Allergan (Abbvie) Luminera, Implantech, Koken, ANTHONY PRODUCTS INC., NOUVAG, Sihuan Pharmaceutical Holdings Group Ltd., and Other prominent players. Major players are focused on introducing innovative products to alleviate menstrual cramps as well as expanding to emerging markets to benefit from high growth opportunities.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
